Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Drugs & Aging|March 6, 2026
Advancing Vaccination Strategies for Older Adults: Insights of the Adult Immunization Board MeetingMarco Del Riccio, Stefania Maggi, Katarzyna Wieczorowska-Tobis, et al.
Vaccines|September 28, 2023
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic ReviewSara Boccalini, Benedetta Bonito, Cristina Salvati, et al.
Immunity, Inflammation and Disease|April 15, 2026
Burden and Characteristics of Respiratory Syncytial Virus-Associated Bronchiolitis in Hospitalized Infants in Italy: A Systematic ReviewAngela Bechini, Cristina Salvati, Marco Del Riccio, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 8, 2024
Anti-rubella seroprevalence assessment in an adult sample population in ItalyAngela Bechini, Beatrice Zanella, Benedetta Bonito, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|November 11, 2024
Respiratory Syncytial Virus associated hospitalisations in children up to 6 years of age in Italy: a systematic reviewAngela Bechini, Cristina Salvati, Benedetta Bonito, et al.
Public Health|December 28, 2023
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic reviewAngela Bechini, Cristina Salvati, Benedetta Bonito, et al.
Aging Clinical and Experimental Research|December 21, 2025
Infectious diseases, infection control, vaccines and long-term care: an European interdisciplinary Council on ageing consensus documentNicola Veronese, Jane Barratt, Eveline Coemans, et al.
Influenza and Other Respiratory Viruses|March 6, 2025
Severity Scale of Influenza and Acute Respiratory Illness Hospitalizations to Support Viral Genomic Surveillance: A Global Influenza Hospital Surveillance Network Pilot StudyBronke Boudewijns, Saverio Caini, Marco Del Riccio, et al.
Cancer Treatment and Research Communications|February 18, 2026
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trialChiara Mattioli, Emanuela Olmetto, Marco Banini, et al.
Pageof 9